Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4

Arch Ophthalmol. 2010 May;128(5):636-8. doi: 10.1001/archophthalmol.2010.53.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Chronic Disease
  • Compassionate Use Trials
  • Corneal Diseases / drug therapy*
  • Corneal Diseases / etiology
  • Diabetes Complications
  • Epithelium, Corneal / drug effects*
  • Epithelium, Corneal / pathology
  • Female
  • Herpes Zoster Ophthalmicus / etiology
  • Humans
  • Male
  • Middle Aged
  • Ophthalmic Solutions / administration & dosage*
  • Thymosin / administration & dosage*

Substances

  • Ophthalmic Solutions
  • thymosin beta(4)
  • Thymosin